New NuVasive CEO Gregory Lucier buys 34k shares — 5 key notes

Spinal Tech

NuVasive's new CEO, Gregory T. Lucier, purchased several company shares in a transaction disclosed yesterday, according to a report from the Daily Rover.

Here are five things to know:

 

1. Mr. Lucier purchased 34,000 shares.

 

2. The shares were purchased at $49.25 on average.

 

3. The total transaction value was $1.6 million.

 

4. There are 1.54 percent of the shares held by the company insiders and 99 percent are held by institutions.

 

5. NuVasive's market cap is $2.3 billion.

 

Mr. Lucier assumed the company's top position after the former CEO stepped down due to compliance issues.

 

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

 

Featured Webinars

Featured Whitepapers